Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

NeoRx begins phase I trial of Pretarget technology in lymphoma

June 25, 1998

Progenics receives payment for cancer vaccine milestone

June 24, 1998

IL-2 fusion protein produces remission in late-stage refractory CTCL

June 23, 1998

Novopharm Biotech's NOVOMAb-G2 IgM completes phase I

June 23, 1998

Russian scientists evaluate the antitumor activity of betaleukin

June 22, 1998

CBER requests additional information for Ontak BLA

June 19, 1998

ICO25 MAb suppresses tumor growth and prolongs survival in preclinical model of colon cancer

June 19, 1998

New dosing regimen of Avax melanoma vaccine results in improved outcome

June 17, 1998

Biomira and Chiron expand Theratope cancer vaccine agreement

June 17, 1998

Combination immunotherapy of renal cell carcinoma: efficacy established in phase II trial

June 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.